Tackling the challenges posed by target flexibility in drug design.
about
Insights into Protein-Ligand Interactions: Mechanisms, Models, and MethodsModelling three-dimensional protein structures for applications in drug design.Utilizing experimental data for reducing ensemble size in flexible-protein docking.ReFlexIn: a flexible receptor protein-ligand docking scheme evaluated on HIV-1 proteasePerspectives on the simulation of protein-surface interactions using empirical force field methods.Efficient incorporation of protein flexibility and dynamics into molecular docking simulationsAccelerated flexible protein-ligand docking using Hamiltonian replica exchange with a repulsive biasing potentialInduced fit docking, and the use of QM/MM methods in dockingMolecular motions in drug design: the coming age of the metadynamics method.In silico fragment-based drug design.Understanding the challenges of protein flexibility in drug design.Simulated annealing molecular dynamics and ligand-receptor contacts analysis for pharmacophore modeling.Receptor-ligand molecular docking.Future De Novo Drug Design.The use of docking-based comparative intermolecular contacts analysis to identify optimal docking conditions within glucokinase and to discover of new GK activators.Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies.Efficient inclusion of receptor flexibility in grid-based protein-ligand docking.
P2860
Q26773062-CCF793AF-A88C-4C4C-932A-5D47899FDA02Q30355473-3571A242-4358-4D9A-A531-D3559B3CE4EEQ34092829-B4FC4A2F-2EF4-4C10-8717-D871397AB15EQ34460848-DCDD1BE6-ED0F-4492-8107-A750DC440E9DQ34616436-504243B4-7349-42DB-BFF3-43E609B15D4EQ35211087-F81CD41B-83BA-4CD1-AF1E-F8A8D74487D4Q36282684-E3BD998F-F1C7-467D-A410-13EE75E20A9AQ37036966-BCE5A7E0-FB0E-46DD-B703-6DD484A0CC35Q37843834-229B4757-696E-4C29-87D3-EFBEF8D6D0B1Q38029118-72F647C1-1094-4256-B68B-1B7A27555F5EQ38594557-6E00209B-B49D-42C8-A196-AD333B6969E8Q38655350-598A7642-4A04-4188-A5BF-9DDF87327519Q38783140-AC2F141D-12BB-4E67-AB85-253572B4D450Q39184034-6DE240A4-2740-4195-8992-F0A19747A64FQ51103643-C2700DAC-7DBF-421D-9CF3-4AE31443A48EQ51410824-52C3E0B2-9201-4A7A-9C50-074A28F9CB25Q51532081-0CEB4EBB-A9C9-4FFB-A5DD-01CB04DF97AB
P2860
Tackling the challenges posed by target flexibility in drug design.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tackling the challenges posed by target flexibility in drug design.
@ast
Tackling the challenges posed by target flexibility in drug design.
@en
type
label
Tackling the challenges posed by target flexibility in drug design.
@ast
Tackling the challenges posed by target flexibility in drug design.
@en
prefLabel
Tackling the challenges posed by target flexibility in drug design.
@ast
Tackling the challenges posed by target flexibility in drug design.
@en
P2860
P1476
Tackling the challenges posed by target flexibility in drug design.
@en
P2093
Christian Beier
P2860
P304
P356
10.1517/17460441003713462
P407
P577
2010-04-01T00:00:00Z